Login
$IBO
$3.87 -$0.12 (3.01%) Close

Ownership

13F as of Q2 2026 · 8.5M shares outstanding

Who owns IBO?

By type of holder
Institutions 0.0% Insiders 21.9% Everyone else 78.1%
Concentration Top 7 holders own 34.3%
Heuszel Frank D 10.3% · Document Security Systems Inc 6.9%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

Notices of proposed sale, last 12 months
$23.1M
1 notice from 1 person
Shares covered
31.9M
374.00% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$11.5M$23.1MNovDecJanFebMarApr 2026: $23.1M without a planAprMayJunJulAugSepOct
Largest proposed sellers
  • DSS Inc. Stockholder $23.1M
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Impact Biomedical Inc.

How patient are the owners?

No 13F manager reports holding IBO.

Super Investors

Investment managers reporting IBO on Form 13F
No 13F manager reports holding IBO yet.

Institutional Funds

Mutual funds and ETFs reporting IBO on Form N-PORT; together they hold 0.0% of the company
No fund reports holding IBO yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
HF
Heuszel Frank D
Insider
Shares
876.1K
% of company
10.26%
Change vs last qtr
—
Held since
—
DS
Document Security Systems Inc
Insider
Shares
589.5K
% of company
6.90%
Change vs last qtr
—
Held since
—

5 more holders behind a free account

See every insider and 5%+ holder of Impact Biomedical Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support